Compass Pathways PLC
Company Profile
Business description
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Contact
33 Broadwick Street
LondonW1F 0DQ
GBRT: +1 716 676-6461
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2025
Employees
186
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,683.40 | 50.00 | 0.58% |
CAC 40 | 7,875.71 | 30.69 | -0.39% |
DAX 40 | 21,413.86 | 91.84 | -0.43% |
Dow JONES (US) | 44,556.04 | 134.13 | 0.30% |
FTSE 100 | 8,566.55 | 4.22 | -0.05% |
HKSE | 20,597.09 | 192.87 | -0.93% |
NASDAQ | 19,654.02 | 262.06 | 1.35% |
Nikkei 225 | 38,831.48 | 33.11 | 0.09% |
NZX 50 Index | 12,844.59 | 60.45 | -0.47% |
S&P 500 | 6,037.88 | 43.31 | 0.72% |
S&P/ASX 200 | 8,416.90 | 42.90 | 0.51% |
SSE Composite Index | 3,229.49 | 21.11 | -0.65% |